ACORDA THERAPEUTICS, INC. — Operating Income by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/50019096-9d6d-41dd-9bf1-83443c88937e/serie/operating-income

Fiscal year	Operating Income	Period	Evidence
FY 2023	$-265.0M	2023-01-01 – 2023-12-31	evidence 0000950170-24-039464
FY 2022	$-35.3M	2022-01-01 – 2022-12-31	evidence 0000950170-23-007948
FY 2021	$-79.0M	2021-01-01 – 2021-12-31	evidence 0001564590-22-010971
FY 2020	$-78.1M	2020-01-01 – 2020-12-31	evidence 0001564590-21-013318
FY 2019	$-311.6M	2019-01-01 – 2019-12-31	evidence 0001564590-20-007789
FY 2018	$38.5M	2018-01-01 – 2018-12-31	evidence 0001564590-19-004986
FY 2017	$-232.8M	2017-01-01 – 2017-12-31	evidence 0001564590-18-003967
FY 2016	$-36.0M	2016-01-01 – 2016-12-31	evidence 0001564590-17-002591
FY 2015	$34.0M	2015-01-01 – 2015-12-31	evidence 0001008848-16-000076
FY 2014	$36.4M	2014-01-01 – 2014-12-31	evidence 0001008848-15-000009
FY 2013	$30.4M	2013-01-01 – 2013-12-31	evidence 0001008848-14-000011
FY 2012	$25.6M	2012-01-01 – 2012-12-31	evidence 0001008848-13-000011
FY 2011	$35.1M	2011-01-01 – 2011-12-31	evidence 0001008848-12-000015
FY 2010	$-8.4M	2010-01-01 – 2010-12-31	evidence 0001008848-12-000015
FY 2009	$-81.3M	2009-01-01 – 2009-12-31	evidence 0001008848-12-000015
FY 2008	$-73.4M	2008-01-01 – 2008-12-31	evidence 0001008848-11-000018

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

ACORDA THERAPEUTICS, INC. — all facts · Revenue · Net Income